Aesthetic & Energy-Based Devices: Global Regulation & Registration

For every regulator below we answer the three questions aesthetic device teams ask first: what class is my laser, filler, or body-contouring platform, how long will registration take, and what will it cost. Our pricing calculator turns those answers into per-market government fees and flat service fees.

What are aesthetic and energy-based devices?

Aesthetic devices — the FDA calls them aesthetic (cosmetic) devices — are the instruments and materials used to improve appearance rather than treat disease: energy-based platforms such as lasers, intense pulsed light (IPL), radiofrequency (RF), and focused ultrasound (HIFU); injectable dermal fillers; microneedling and body-contouring systems; and threads and implants placed for cosmetic reasons. Medical aesthetic devices sit on a spectrum from clearly regulated, like an ablative laser or a hyaluronic acid filler, to genuinely consumer wellness gadgets, and the boundary is where regulators spend their attention.

The catch is that every jurisdiction draws the line differently. A radiofrequency skin-tightening device is a Class II device in the United States, an injectable filler is Class III, and in Europe a device with no medical purpose at all — a laser sold purely to remove hair, an implant placed only for aesthetics — is still captured under MDR Annex XVI. Because the same product can be a light-touch notification in one market and a full clinical dossier in another, a market-by-market classification analysis is the first deliverable of any serious aesthetic device program. Every cost below has two parts: the government fee, and our own flat annual service fee per market, from US$1,000 per year in the US (device listing and US Agent representation) and from US$2,000 per year in most other markets. Exact current figures live in our pricing calculator.

FDA aesthetic device regulation (United States)

FDA regulates aesthetic devices through the same risk framework as any other device, and it splits the category sharply: most energy-based devices are moderate-risk Class II, while injectable dermal fillers are high-risk Class III.

• Classification. Energy-based devices — lasers, IPL, radiofrequency, and focused ultrasound (HIFU) — are typically Class II and cleared through a 510(k) against a predicate; microneedling devices are Class II when they carry a medical claim. Injectable dermal fillers are Class III and require premarket approval (PMA) supported by clinical data. Laser platforms carry a parallel obligation under FDA's Electronic Product Radiation Control (EPRC) program, separate from the 510(k): every laser product marketed in the US — even consumer devices with no medical claim — must be certified to the federal laser performance standard (21 CFR 1040.10/1040.11), or to IEC 60825-1 and IEC 60601-2-22 under Laser Notice 56, with a laser product report filed with CDRH (whose accession number is checked at import), certification labeling, and annual reports thereafter.
• Timeline. A 510(k) typically runs 3 to 9 months end to end including preparation and FDA interaction; a Class III PMA for a filler plans for well over a year and usually needs a clinical study. A Pre-Submission meeting adds a few weeks up front and routinely saves review cycles later.
• Cost. Government fees: US$26,067 for a standard 510(k) review (US$6,517 for qualified small businesses) plus US$11,423 per year in establishment registration; a PMA runs far higher. Our flat US$1,000 per year covers FDA establishment registration and device listing maintenance plus US Agent representation; 510(k) preparation and submission are scoped as a separate project.

Start from our United States market page for the full FDA pathway.

Body contouring devices: cryolipolysis, RF, and HIFU

Non-invasive body contouring is the most searched corner of the aesthetic market — cryolipolysis, radiofrequency, focused ultrasound (HIFU), laser lipolysis, and electromagnetic muscle-stimulation platforms that reduce fat or tighten skin without surgery. In the US these are almost all Class II devices cleared through 510(k) against a predicate, with device-specific special controls; a genuinely novel mechanism without a predicate goes through De Novo. The real regulatory work is defining the intended use precisely — "fat reduction," "circumference reduction," and "skin tightening" are different claims with different evidence expectations — and matching it to the right predicate. We settle that claim-and-predicate analysis before the submission and carry the same intended-use definition into every other market so the dossier stays consistent.

EU MDR and Annex XVI: aesthetic device classification and CE marking

Europe regulates aesthetic devices on two tracks. Devices with a medical purpose follow the normal MDR classification rules with a notified body; devices with no medical purpose — purely cosmetic lasers and IPL, dermal fillers for wrinkle-filling, equipment for fat reduction, colored non-corrective contact lenses — are pulled in by MDR Annex XVI, whose common specifications (Regulation (EU) 2022/2346) now apply device-grade requirements to products that used to sit outside regulation.

• Classification. Aesthetic devices with a medical purpose classify like any other device under MDR — energy-based devices commonly Class IIa or IIb, injectable fillers Class III. Annex XVI products without a medical purpose are classified too: active products are reclassified by Implementing Regulation (EU) 2022/2347 — lasers and IPL are Class IIa for hair removal and Class IIb for other skin treatments, and fat-reduction equipment is Class IIb — while non-active products such as purely aesthetic dermal fillers follow the normal MDR Annex VIII rules (absorbable fillers Class III). The common specifications (Regulation (EU) 2022/2346) add device-grade safety, risk-management, and clinical-evaluation requirements, and a notified body is required for anything above Class I.
• Timeline. Plan 9 to 18 months with a notified body for a first Class IIa or IIb certification; Class III fillers and higher-risk implants take longer and require clinical evaluation. Notified body capacity is the binding constraint on the schedule.
• Cost. There is no central government fee; the money goes to the notified body — typically €30,000 to €70,000 across a first Class IIa certification cycle, higher for Class III — plus annual surveillance and MDR-grade documentation. Our EU Authorized Representative service is a flat annual fee from US$2,000, capped at US$4,000 as your portfolio grows, and covers EC REP representation, document review, and EUDAMED support; CE-marking work with your notified body is scoped separately.

Annex XVI strategy should shape your EU plan early; see the European Union market page for the MDR route.

Aesthetic device registration in Brazil and Latin America (ANVISA)

Brazil regulates aesthetic and energy-based devices as medical devices through ANVISA, and this is where reliance pays off: a prior FDA clearance or CE certificate materially strengthens the ANVISA dossier, an asymmetry we document in our aesthetic device global market-access report. Mexico's COFEPRIS is the region's second gate. Both require a local representative — we act as Brazil Registration Holder without taking control of your registration.

• Classification. ANVISA classifies aesthetic devices under its risk framework (Classes I-IV, aligned to the IMDRF model): most energy-based devices land in Class II or III, injectable fillers in Class III or IV. Class I-II products can use the streamlined notificação route; Class III-IV requires full registro with deeper technical evidence.
• Timeline. Notification is typically a matter of weeks; Class III-IV registration plans for 6 to 12 months. In Mexico, COFEPRIS runs 6 to 12 months on the standard route, faster where reliance on FDA or CE approvals applies.
• Cost. ANVISA government fees: R$1,406 to notify a Class I-II product; Class III-IV family registration runs R$8,510-19,856, plus a one-time international B-GMP certification of R$72,805 where required. COFEPRIS charges MX$16,499-30,798 per product by class. Our registration service starts at US$2,000 per year (US$3,000 for high-risk classes) in both markets.

Start with the Brazil market page; labeling and instructions for use are prepared natively in Portuguese and Spanish.

Aesthetic device registration in Asia-Pacific: Singapore first, then ASEAN

Most overseas aesthetic device makers enter Asia-Pacific through Singapore: HSA works in English, follows the IMDRF model, and rewards a strong FDA or CE dossier with a fast abridged review. A Singapore approval then anchors expansion across ASEAN — Malaysia, Thailand, Indonesia, Vietnam, the Philippines — where reliance-friendly frameworks make each additional market incremental rather than a new program. Korea and Japan are large, mature aesthetic markets with their own systems and languages. China is the biggest market but the hardest entry — local type testing and the longest timelines — so treat it as its own program when the business case justifies it, not a default stop.

• Classification. Singapore's HSA uses risk classes A through D; energy-based devices commonly fall in Class B or C and injectable fillers in Class C or D. ASEAN members track the same IMDRF-style model. Japan classifies against JMDN codes, Korea's MFDS uses Classes I-IV, and China places most aesthetic energy devices in Class II or III with injectable fillers in Class III.
• Timeline. HSA abridged evaluation with a reference approval targets 100 to 220 working days by class (roughly 5 to 10 months); devices with a reference approval and a clean multi-year marketing history can qualify for HSA's immediate route (Class B, registered on submission) or expedited Class C review (120 working days); ASEAN registrations typically run 3 to 9 months per market on the back of the same dossier. Japan plans for 9 to 14 months via PMDA, Korea 6 to 12 months including KGMP, and China 12 to 24 months including type testing.
• Cost. Singapore's government fees are light: a SGD 560 application plus SGD 2,010-6,250 evaluation by class, and ASEAN peers are similar (Malaysia MYR 500 plus MYR 750-3,000 registration by class; Thailand THB 3,100-74,000). China's NMPA fees for imported Class II-III run roughly RMB 210,000-310,000 before type testing. Our registration service starts at US$2,000 per year across Singapore and ASEAN; China, Japan, and Korea are quoted flat per market on the same model.

One well-built reference dossier does most of the region's work — sequencing is the strategy. See the Singapore, Malaysia, Thailand, Japan, South Korea, and China market pages.

Aesthetic device registration in Saudi Arabia and MENA (SFDA)

The Gulf is one of the fastest-growing aesthetic markets in our portfolio, and its regulators are built around reliance: a strong FDA, CE, or other reference approval does most of the work if the dossier is assembled correctly. SFDA regulates aesthetic and energy-based devices and requires a local Authorized Representative; the UAE's MOHAP is the second gate.

• Classification. SFDA classifies devices into risk classes A through D on the IMDRF model, generally mirroring your reference-market class; the UAE and other MENA authorities lean on the reference approval's classification.
• Timeline. With a reference approval in hand, SFDA marketing authorization (MDMA) typically closes in 2 to 6 months, and UAE registration runs a similar range. Without a reference approval, expect materially longer.
• Cost. Government fees across the Gulf are modest — generally a few thousand US dollars' equivalent per authority — so the real spend is dossier assembly, Arabic labeling where required, and local representation. We quote MENA registration programs flat per market, on the same transparent model as our calculator markets.

See the Saudi Arabia and UAE market pages.

Evidence, quality system, and lifecycle

Aesthetic devices live or die on evidence that the energy or material does what the label claims and nothing it does not. We set up ISO 13485 and FDA QMSR processes, plan biocompatibility testing to ISO 10993 for anything in skin or tissue contact — critical for injectable fillers and microneedling — and build the electrical, laser, and photobiological safety evidence energy-based devices need (IEC 60601-1, IEC 60601-2-22 for laser equipment, IEC 60601-2-57 for IPL and other non-laser light sources, and IEC 60825-1 laser safety). Clinical evidence is planned once for reuse across FDA, EU MDR, and Asia-Pacific submissions; for Class III fillers and higher-risk platforms, that clinical file is the heart of the dossier. Where your platform is network-connected or app-controlled, we maintain cybersecurity documentation to match. After launch, complaint handling, adverse-event reporting, and change assessments keep every registration current.

One program, every major market

An aesthetic device program is a sequencing problem: pick the anchor market, build the clinical and safety evidence once, and reuse the intended-use definition, testing, and QMS artifacts everywhere else. The reliance asymmetry works in your favor — an FDA clearance or CE certificate shortens most registrations that follow. We run the full program from a single team — strategy, submissions, in-country representation, and post-market maintenance — with transparent government fees and timelines in our pricing calculator.